Consistent with a reduction in the number of stem-like cancer cells, we observed that knockdown of ABCC3 led to reduced tumor growth compared to control NT cells, which was further reduced on doxorubicin treatment (Fig 7G, 7H and S8 Table). This evidence concerns the gene ABCC3 and cancer.